Use of natural or artificial isorhodanate analog compound JC-5411 in preparing transcription factor SP1 inhibitor
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- JC (WUXI) CO INC
- Publication Date
- 2006-05-10
- Estimated Expiration
- Not applicable · inactive patent
Smart Images
Figure 1 Figure 2 Figure 3
Abstract
Description
technical field
[0001] The invention belongs to the field of medical applications, and relates to JC-5411 series compounds, which use isothiocyanate as the core structure, including natural and artificially synthesized isothiocyanates. This invention uses the latest molecular biology technology to prove for the first time that JC-5411 series compounds can regulate the expression of androgen receptor gene in cells and inhibit the abnormal proliferation of prostate cells. Rat benign prostatic enlargement (BPH), and growth of prostate cancer cells. Furthermore, the present invention provides a brand-new method for preventing and treating prostatic enlargement and prostate cancer that is effective. The series of compounds also have the advantages of low toxic and side effects, stable chemical and biological properties, low production cost, etc., and have wide applicability. Background technique
[0002] BPH, also known as benign prostatic enlargement (BPH), and prostate cancer...